2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Pancreatic Neoplasms
6
Prostatic Neoplasms
4
Nasopharyngeal Carcinoma
4
Carcinoma, Hepatocellular
4
Radiation Injuries
3
Carcinoma, Non-Small-Cell Lung
3
Sarcoma
2
Melanoma
2
Carcinoma
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Rare Diseases
1
Pancreatic Cancer Non-resectable
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Meningioma
1
Locally Advanced Pancreatic Cancer
1
Glioma
1
Chondrosarcoma
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Doxorubicin
142
Ifosfamide
85
Radiotherapy
82
Cyclophosphamide
72
Gemcitabine
63
Filgrastim
54
pembrolizumab
43
pazopanib
40
Etoposide
39
Docetaxel
39
Vincristine
37
Trabectedin
37
Cisplatin
35
Nivolumab
32
Magnetic Resonance Spectroscopy
26
Irinotecan
26
Carboplatin
25
Temozolomide
23
Surgical Procedures, Operative
23
Radiation
22
Ipilimumab
22
Bevacizumab
20
Blood Specimen Collection
19
Granulocyte Colony-Stimulating Factor
18
Biopsy
18
eribulin
17
Sirolimus
17
Mesna
17
Melphalan
17
Dactinomycin
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Sarcoma
×
Heavy Ion Radiotherapy
×
Clear all
NCT04219202
2026-03-10
Retro-Ion
University Hospital Heidelberg
Phase NA
Recruiting
64 enrolled
NCT07250334
2025-11-26
SARCOMA-01
Yonsei University
Phase NA
Not yet recruiting
60 enrolled